Camad, Saima M.

HRN: 23-19-26  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/07/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/07/2025
01/14/2025
IV
2.25g
Every 6 Hours
UTI Complicated
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: